Cuijian W. Zhang
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Drug combination choices of 5α-reductase inhibitors and α-blockers in patients with benign prostatic hyperplasia: a study based on the FAERS database.
Journal: Frontiers in medicine
Published: April 30, 2026
Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer.
Journal: The New England journal of medicine
Published: October 22, 2025
Vitamin C enhances cisplatin sensitivity in bladder cancer via 5hmC-mediated epigenetic modulation of ATF4.
Journal: Clinical epigenetics
Published: September 24, 2025
Disitamab vedotin (RC48-ADC) combined with immunotherapy as neoadjuvant therapy for localized muscle-invasive bladder cancer: a multicenter real-world study.
Journal: NPJ precision oncology
Published: September 17, 2025
Diagnostic performance of regional systematic biopsy for prostate cancer stratified by PI-RADS and histologic zones.
Journal: Insights into imaging
Published: February 13, 2024
Reply to Fabrizio Di Maida, Anna Cadenar, Andrea Mari, and Andrea Minervini's Letter to the Editor re: Xuesong Li, Weifeng Xu, Shubo Fan, et al. Robot-assisted Partial Nephrectomy with the Newly Developed KangDuo Surgical Robot Versus the da Vinci Si Surgical System: A Double-center Prospective Randomized Controlled Noninferiority Trial. Eur Urol Focus 2023:9:133-40.
Journal: European urology focus
Published: March 19, 2023
Comparative analysis of salvage partial nephrectomy versus radical nephrectomy after the failure of initial partial nephrectomy.
Journal: Urologic oncology
Published: March 16, 2023
Integrated analysis to identify the prognostic and immunotherapeutic roles of coagulation-associated gene signature in clear cell renal cell carcinoma.
Journal: Frontiers in immunology
Published: November 24, 2022
Surgical techniques and oncological outcomes of pure transperitoneal laparoscopic radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Journal: Translational andrology and urology
Published: October 03, 2022
Identification of a claudin-low subtype in clear cell renal cell carcinoma with implications for the evaluation of clinical outcomes and treatment efficacy.
Journal: Frontiers in immunology
Published: August 16, 2022
Last Updated: 09/26/2026